Skip to main content
OpenTrials

Clinical trial condition

HIV Infection

Explore clinical trials studying HIV Infection. Study availability and eligibility vary by location and protocol.

540 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

HIV Infection trial results

Completed

HLA-B*5701 And Hypersensitivity To Abacavir

NCT00373945

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Beverly Hills, California, United States
  • GSK Investigational Site Loma Linda, California, United States
View all 55 locations
View Trial Details
Completed

Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage

NCT00556634

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • Hospital Torrecardenas Almería, Almeria, Spain
  • Hospital Universitario Puerta del Mar Cadiz, Spain
  • Hospital de Jerez Jerez de la Frontera, Cadiz, Spain
  • Hospital Universitario Reina Sofía Córdoba, Cordoba, Spain
View Trial Details
Completed

Pharmacokinetic Study Of EPZICOM Tablet

NCT00337922

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Nagano, Japan
  • GSK Investigational Site Osaka, Japan
  • GSK Investigational Site Shizuoka, Japan
  • GSK Investigational Site Tokyo, Japan
View Trial Details
Completed

A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701

NCT00435838

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Graz, Austria
  • GSK Investigational Site Innsbruck, Austria
  • GSK Investigational Site Salzburg, Austria
  • GSK Investigational Site Vienna, Austria
View all 25 locations
View Trial Details
Completed

Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults

NCT00343941

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Bergamo, Lombardy, Italy
  • GSK Investigational Site Busto Arsizio (VA), Lombardy, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
View Trial Details

Related conditions